EARNEST Partners’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,842,926
| Closed | -$139M | – | 308 |
|
|
2026
Q1 | $139M | Sell |
1,842,926
-47,557
| -3% | -$3.58M | 0.57% | 60 |
|
|
2025
Q4 | $141M | Sell |
1,890,483
-20,708
| -1% | -$1.51M | 0.6% | 63 |
|
|
2025
Q3 | $129M | Buy |
1,911,191
+26,877
| +1% | +$1.78M | 0.56% | 62 |
|
|
2025
Q2 | $123M | Buy |
1,884,314
+16,526
| +0.9% | +$991K | 0.55% | 70 |
|
|
2025
Q1 | $115M | Sell |
1,867,788
-27,310
| -1% | -$1.81M | 0.55% | 71 |
|
|
2024
Q4 | $137M | Buy |
1,895,098
+68,791
| +4% | +$5.37M | 0.61% | 60 |
|
|
2024
Q3 | $149M | Sell |
1,826,307
-51,899
| -3% | -$4.15M | 0.65% | 56 |
|
|
2024
Q2 | $139M | Buy |
1,878,206
+64,178
| +4% | +$4.81M | 0.65% | 54 |
|
|
2024
Q1 | $141M | Buy |
1,814,028
+99,084
| +6% | +$7.37M | 0.65% | 56 |
|
|
2023
Q4 | $123M | Buy |
1,714,944
+262,950
| +18% | +$18.3M | 0.61% | 60 |
|
|
2023
Q3 | $101M | Buy |
1,451,994
+92,658
| +7% | +$7M | 0.58% | 67 |
|
|
2023
Q2 | $110M | Buy |
1,359,336
+89,824
| +7% | +$7.34M | 0.62% | 61 |
|
|
2023
Q1 | $102M | Buy |
1,269,512
+64,590
| +5% | +$5.2M | 0.59% | 65 |
|
|
2022
Q4 | $90.1M | Buy |
1,204,922
+22,528
| +2% | +$1.6M | 0.55% | 76 |
|
|
2022
Q3 | $76.3M | Buy |
1,182,394
+64,144
| +6% | +$4.44M | 0.51% | 84 |
|
|
2022
Q2 | $77.5M | Buy |
1,118,250
+133,581
| +14% | +$9.92M | 0.52% | 83 |
|
|
2022
Q1 | $75.6M | Buy |
984,669
+40,774
| +4% | +$2.93M | 0.45% | 93 |
|
|
2021
Q4 | $72.3M | Buy |
943,895
+53,829
| +6% | +$3.96M | 0.42% | 93 |
|
|
2021
Q3 | $65.7M | Buy |
890,066
+77,526
| +10% | +$5.81M | 0.4% | 98 |
|
|
2021
Q2 | $54.2M | Buy |
812,540
+214,117
| +36% | +$14.3M | 0.32% | 111 |
|
|
2021
Q1 | $44.5M | Buy |
598,423
+110,610
| +23% | +$8.4M | 0.27% | 120 |
|
|
2020
Q4 | $35.5M | Buy |
487,813
+94,661
| +24% | +$6.68M | 0.25% | 122 |
|
|
2020
Q3 | $26.1M | Buy |
393,152
+19,629
| +5% | +$1.24M | 0.23% | 127 |
|
|
2020
Q2 | $21.3M | Buy |
373,523
+108,750
| +41% | +$5.34M | 0.2% | 132 |
|
|
2020
Q1 | $9.29M | Buy |
264,773
+11,252
| +4% | +$536K | 0.1% | 156 |
|
|
2019
Q4 | $13.2M | Buy |
253,521
+77,278
| +44% | +$3.85M | 0.1% | 162 |
|
|
2019
Q3 | $8.9M | Buy |
176,243
+9,883
| +6% | +$486K | 0.08% | 172 |
|
|
2019
Q2 | $7.99M | Sell |
166,360
-758
| -0.5% | -$35K | 0.07% | 174 |
|
|
2019
Q1 | $8.09M | Sell |
167,118
-3,240
| -2% | -$146K | 0.08% | 168 |
|
|
2018
Q4 | $7M | Sell |
170,358
-5,676
| -3% | -$233K | 0.08% | 168 |
|
|
2018
Q3 | $7.21M | Buy |
176,034
+974
| +0.6% | +$39.4K | 0.06% | 173 |
|
|
2018
Q2 | $6.96M | Sell |
175,060
-6,152
| -3% | -$237K | 0.07% | 171 |
|
|
2018
Q1 | $6.77M | Buy |
181,212
+1,250
| +0.7% | +$50.5K | 0.06% | 168 |
|
|
2017
Q4 | $7.69M | Sell |
179,962
-25,196
| -12% | -$1M | 0.07% | 164 |
|
|
2017
Q3 | $7.53M | Buy |
205,158
+4,152
| +2% | +$168K | 0.08% | 157 |
|
|
2017
Q2 | $9.12M | Sell |
201,006
-4,254
| -2% | -$188K | 0.1% | 151 |
|
|
2017
Q1 | $8.73M | Buy |
205,260
+205,138
| +168,146% | +$8.36M | 0.09% | 154 |
|
|
2016
Q4 | $5K | Buy |
+122
| New | +$4.71K | ﹤0.01% | 675 |
|
Other funds holding HOLX
EARNEST Partners's HOLX Position: Q2 2026 in Review
EARNEST Partners sold out of Hologic (HOLX) in Q2 2026, closing a stake of 1,842,926 shares — an estimated $139M sold.
EARNEST Partners first reported a position in HOLX in Q4 2016 and held it in 38 quarters. The position peaked at $149M in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- EARNEST Partners reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- EARNEST Partners sold 1,842,926 Hologic shares in Q2 2026, an estimated $139M.
- EARNEST Partners first reported a position in Hologic in Q4 2016 and held it in 38 quarters.
- EARNEST Partners's Hologic position peaked at $149M in Q3 2024.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on EARNEST Partners's 13F filing for Q2 2026, filed 13 Aug 2026.